Claudio Rapezzi

44.3k citations
473 papers · 37.8k · 16 hit papers · h-index 82

Impact in

    • Cardiomyopathy and Myosin Studies
    • Cardiac electrophysiology and arrhythmias
    • Cardiac pacing and defibrillation studies
    • Cardiovascular Function and Risk Factors
    • Heart Failure Treatment and Management
    • Amyloidosis: Diagnosis, Treatment, Outcomes

Papers in

    • Cardiomyopathy and Myosin Studies 81
    • Cardiac pacing and defibrillation studies 27
    • Acute Myocardial Infarction Research 20
    • Heart Failure Treatment and Management 19
    • Cardiac electrophysiology and arrhythmias 17
    • Amyloidosis: Diagnosis, Treatment, Outcomes 163

Claudio Rapezzi

465 papers receiving 36.3k citations

Claudio Rapezzi's Hit Papers

Diagnosis and Treatment of Cardiac Amyloidosis. A Position Statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 2021 · 254 citations
2540+6+12Years since publication1k2k3k

Peers

Claudio Rapezzi
Comparison fields: 5 of 170
  • Cardiology and Cardiovascular Medicine 15.8k
  • Molecular Biology 14.7k
  • Epidemiology 3.3k
  • Radiology, Nuclear Medicine and Imaging 1.6k
  • Health Informatics 84
Replace Erwan Donal with:
Erwan Donal France
Henning Bundgaard Denmark
James Moon United Kingdom
Gaetano Thiene Italy
Barbara J.M. Mulder Netherlands
Bernard Prendergast United Kingdom
Allard C. van der Wal Netherlands
JAGDISH W. BUTANY Canada
Marcus Y. Chen United States
Grover M. Hutchins United States
Claudio Rapezzi relative to Erwan Donal France Erwan Donal's profile →
Citations per field
00.5×5×10×13.8×
Erwan Donal · 1×
Citations per year

Countries citing papers authored by Claudio Rapezzi

Since Specialization
Citations

This map shows the geographic impact of Claudio Rapezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Rapezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Rapezzi more than expected).

Fields of papers citing papers by Claudio Rapezzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Rapezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Rapezzi. The network helps show where Claudio Rapezzi may publish in the future.

Co-authors

The 25 scholars most cited alongside Claudio Rapezzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Claudio Rapezzi Line = papers co-authored together Claudio Rapezzi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 473 papers — load more, or switch the sort, to bring in the rest.

#Work
1
2015 ESC Guidelines for the management of infective endocarditis
Hit paper breakdown →
20153651
2
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Hit paper breakdown →
20143425
3
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Hit paper breakdown →
20072214
4
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Hit paper breakdown →
20182024
5
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Hit paper breakdown →
20161551
6
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
Hit paper breakdown →
2013923
7
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
Hit paper breakdown →
2014804
8
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
Hit paper breakdown →
2021788
9
Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy
Hit paper breakdown →
2005744
10
Systemic Cardiac Amyloidoses
Hit paper breakdown →
2009633
11
Guideline of transthyretin-related hereditary amyloidosis for clinicians
Hit paper breakdown →
2013561
12
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Hit paper breakdown →
2007499
13 2016435
14
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
Hit paper breakdown →
2019419
15
Long-Term Safety of Drug-Eluting and Bare-Metal Stents
Hit paper breakdown →
2015385
16 2010379
17 2017369
18 2019349
19 2012328
20 2008327

About Claudio Rapezzi

Claudio Rapezzi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 473 papers that have together received 37.8k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (163 papers), Cardiomyopathy and Myosin Studies (81 papers), Cardiac pacing and defibrillation studies (27 papers), Acute Myocardial Infarction Research (20 papers), Heart Failure Treatment and Management (19 papers), Cardiac Imaging and Diagnostics (19 papers), Aortic Disease and Treatment Approaches (17 papers) and Cardiac electrophysiology and arrhythmias (17 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (15.8k citations), Molecular Biology (14.7k citations), Epidemiology (3.3k citations), Radiology, Nuclear Medicine and Imaging (1.6k citations) and Health Informatics (84 citations). Claudio Rapezzi has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Elena Biagini, Angelo Branzi, Perry Mark Elliott, Ornella Leone, Lorenzo Monserrat, Fabrizio Salvi, Maria Letizia Bacchi Reggiani, William John McKenna, Candida Cristina Quarta and Massimiliano Lorenzini. Their work appears in journals such as European Heart Journal, European Journal of Heart Failure, Journal of the American College of Cardiology, International Journal of Cardiology and The American Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact